ENG and breast carcinoma: Previous studies demonstrated that Lm-LLO-CD105A likely impedes tumor growth by its ability to target tumor vasculature-associated CD105 expression in a murine model of breast cancer in which the tumor cells themselves do not express CD105 (19, 43).